Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


Improvements still needed with front-line treatment

Written by | 10 Sep 2019 | All Medical News

Although early stage HL patients have an outstanding result, according to Prof Stephen Ansell (Rochester, USA), he argues that those with stage 3 and 4 disease don’t do nearly as well.

Written by Esther Drain.

Prof Peter Johnson (Southampton, UK) and Dr Anna Sureda (Barcelona, Spain) discuss how to select late stage patients who will benefit most from novel agents in the up front setting.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.